Joanne B. Weidhaas, MD, Ph.D., MSM
Professor of Radiation Oncology at the David Geffen School of Medicine UCLA
Co-Founder of MiraDx
Founder of MiraKind
Joanne is a co-founder of MiraDx and Professor at the David Geffen School of Medicine at UCLA, in the Department of Therapeutic Radiology. Her pioneering research led to the co-discovery of the KRAS-variant, a strong predictor of cancer risk and tumor biology. Her passion for empowering individuals to take charge of their health led her to found MiraDx, a genomics company dedicated to giving people and their doctors actionable information to prevent and treat cancer more effectively.
Joanne completed her oncology training at Memorial Sloan-Kettering Cancer Center and previously served as the Chief of the Breast Cancer Radiation Service at Yale Cancer Center and the Section Chief, Breast Cancer, Yale Cancer Center. She has recently moved to UCLA as Division Head, Translational Research. Her dual role as a clinician and a researcher enables her to apply genetic breakthroughs to the benefit of her patients.
Joanne earned an MD/Ph.D. from Tufts University, and completed her Residency in Oncology at the Memorial Sloan-Kettering Cancer Center. She earned a Masters in Business Management from Stanford Business School. She holds a BS in biology from Yale University.
View her publication record here